RDY
Dr. Reddy's Laboratories Ltd. Earnings
$13.35
Earnings Summary
Revenue | $83586Mn |
Net Profits | $14133Mn |
Net Profit Margins | 16.91% |
PE Ratio | 18.16 |
Dr. Reddy's Laboratories Ltd.’s revenue jumped 15.85% since last year same period to $83586Mn in the Q4 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 4.27% jump in its revenue since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit jumped 2.49% since last year same period to $14133Mn in the Q4 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 12.59% jump in its net profits since last 3-months.
Dr. Reddy's Laboratories Ltd.’s net profit margin fell -11.53% since last year same period to 16.91% in the Q4 2024. On a quarterly growth basis, Dr. Reddy's Laboratories Ltd. has generated 7.97% jump in its net profit margins since last 3-months.
Dr. Reddy's Laboratories Ltd.’s price-to-earnings ratio after this Q4 2024 earnings stands at 18.16.
Earnings per share (EPS) Estimates
EPS Estimate Current Quarter | 16.15 |
EPS Estimate Current Year | 16.15 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current quarter stand at 16.15 - a 1548.06% jump from last quarter’s estimates.
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) estimates for the current year stand at 16.15.
Key Ratios
Earning Per Share (EPS) | 16.94 |
Return on Assets (ROA) | 0.1 |
Return on Equity (ROE) | 0.18 |
Dr. Reddy's Laboratories Ltd.’s earning per share (EPS) fell -79.55% since last year same period to 16.94 in the Q4 2024. This indicates that the Dr. Reddy's Laboratories Ltd. has generated -79.55% annual rate of fall in its earning per share (EPS) in the last 4 quarters.
Return on assets (ROA) indicates the profitability of the company in relation to its total assets. This ratio tells the financial health of the company. The higher the ROA, the better the company’s financial health. If any company has a ROA in the range of 5% to 20% - it is generally considered good. ROA above 20% is generally considered excellent. Dr. Reddy's Laboratories Ltd.’s return on assets (ROA) stands at 0.1.
The Return On Equity ratio indicates a company’s ability to turn equity capital received from shareholders into profits. ROE highlights the efficiency of equity capital in running the business. Generally, a return on equity in double digits is considered good. Dr. Reddy's Laboratories Ltd.’s return on equity (ROE) stands at 0.18.
Earnings Calendar
| Earnings Date | Estimated EPS | Reported EPS | Surprise % |
|---|---|---|---|
2024-12-31 | 16.15 | 16.94 | 4.86% |
2024-09-30 | 0.98 | 0.18 | -81.63% |
2024-06-12 | 68.45 | 78.35 | 14.46% |
